AB Science S.A. (OTCMKTS:ABSCF – Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 30th, there was short interest totaling 21,788 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ? days.
AB Science Price Performance
AB Science stock opened at $1.12 on Thursday. AB Science has a twelve month low of $1.12 and a twelve month high of $1.37. The stock has a 50 day moving average of $1.12 and a two-hundred day moving average of $1.17.
About AB Science
AB Science is a France-based biopharmaceutical company focused on the discovery, development and commercialization of targeted therapies for human and veterinary medicine. The company’s research centers on tyrosine kinase inhibitors, a class of medicines designed to modulate signaling pathways involved in cancer, inflammation and other diseases.
Its lead product is masitinib, an orally administered tyrosine kinase inhibitor that targets pathways involving mast cells and certain other immune and tumor-related cells.
Featured Stories
- Five stocks we like better than AB Science
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for AB Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Science and related companies with MarketBeat.com's FREE daily email newsletter.
